Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kisseberth

Showing results (31-40 of 88) with videos related to

Pageof 9
Sort By:
BMC Veterinary Research|August 15, 2015
Characterization of STAT3 expression, signaling and inhibition in feline oral squamous cell carcinomaMegan E Brown, Misty D Bear, Thomas J Rosol, et al.
BMC Veterinary Research|October 2, 2013
Evaluation of the adverse event profile and pharmacodynamics of toceranib phosphate administered to dogs with solid tumors at doses below the maximum tolerated doseLuis Feo Bernabe, Roberta Portela, Sandra Nguyen, et al.
BMC Veterinary Research|December 19, 2012
Biologic activity of the novel small molecule STAT3 inhibitor LLL12 against canine osteosarcoma cell linesJason I Couto, Misty D Bear, Jiayuh Lin, et al.
Journal of the American Veterinary Medical Association|December 1, 1984
Industrial lead contamination of an Illinois wildlife refuge and indigenous small mammalsW C Kisseberth, J P Sundberg, R W Nyboer, et al.
Journal of the American Animal Hospital Association|January 6, 2009
Adjuvant CCNU (lomustine) and prednisone chemotherapy for dogs with incompletely excised grade 2 mast cell tumorsKenji Hosoya, William C Kisseberth, Francisco J Alvarez, et al.
Plos One|November 13, 2015
Human Genetic Relevance and Potent Antitumor Activity of Heat Shock Protein 90 Inhibition in Canine Lung Adenocarcinoma Cell LinesFrancisco Clemente-Vicario, Carlos E Alvarez, Jennie L Rowell, et al.
Journal of Veterinary Internal Medicine|October 27, 2006
Phase I evaluation of low-dose suramin as chemosensitizer of doxorubicin in dogs with naturally occurring cancersCarrie E Kosarek, Xiao Hu, C Guillermo Couto, et al.
Journal of Veterinary Internal Medicine|February 22, 2008
Phase I clinical evaluation of carboplatin in tumor-bearing cats: a Veterinary Cooperative Oncology Group studyW C Kisseberth, D M Vail, J Yaissle, et al.
Veterinary and Comparative Oncology|September 17, 2009
3-Phosphoinositide-dependent protein kinase-1/Akt signalling and inhibition in a canine prostate carcinoma cell lineF J Alvarez, S Murahari, C G Couto, et al.
Veterinary and Comparative Oncology|June 12, 2026
Use of the IlluminOss Photodynamic Bone Stabilisation System Following Stereotactic Body Radiation Therapy for Limb-Sparing in Six Dogs With Presumptive Appendicular OsteosarcomaEmily A Pope, Vincent A Wavreille, Janis L Lapsley, et al.
Pageof 9

Showing results (31-40 of 88) with videos related to

Sort By:
Pageof 9
BMC Veterinary Research|August 15, 2015
Characterization of STAT3 expression, signaling and inhibition in feline oral squamous cell carcinomaMegan E Brown, Misty D Bear, Thomas J Rosol, et al.
BMC Veterinary Research|October 2, 2013
Evaluation of the adverse event profile and pharmacodynamics of toceranib phosphate administered to dogs with solid tumors at doses below the maximum tolerated doseLuis Feo Bernabe, Roberta Portela, Sandra Nguyen, et al.
BMC Veterinary Research|December 19, 2012
Biologic activity of the novel small molecule STAT3 inhibitor LLL12 against canine osteosarcoma cell linesJason I Couto, Misty D Bear, Jiayuh Lin, et al.
Journal of the American Veterinary Medical Association|December 1, 1984
Industrial lead contamination of an Illinois wildlife refuge and indigenous small mammalsW C Kisseberth, J P Sundberg, R W Nyboer, et al.
Journal of the American Animal Hospital Association|January 6, 2009
Adjuvant CCNU (lomustine) and prednisone chemotherapy for dogs with incompletely excised grade 2 mast cell tumorsKenji Hosoya, William C Kisseberth, Francisco J Alvarez, et al.
Plos One|November 13, 2015
Human Genetic Relevance and Potent Antitumor Activity of Heat Shock Protein 90 Inhibition in Canine Lung Adenocarcinoma Cell LinesFrancisco Clemente-Vicario, Carlos E Alvarez, Jennie L Rowell, et al.
Journal of Veterinary Internal Medicine|October 27, 2006
Phase I evaluation of low-dose suramin as chemosensitizer of doxorubicin in dogs with naturally occurring cancersCarrie E Kosarek, Xiao Hu, C Guillermo Couto, et al.
Journal of Veterinary Internal Medicine|February 22, 2008
Phase I clinical evaluation of carboplatin in tumor-bearing cats: a Veterinary Cooperative Oncology Group studyW C Kisseberth, D M Vail, J Yaissle, et al.
Veterinary and Comparative Oncology|September 17, 2009
3-Phosphoinositide-dependent protein kinase-1/Akt signalling and inhibition in a canine prostate carcinoma cell lineF J Alvarez, S Murahari, C G Couto, et al.
Veterinary and Comparative Oncology|June 12, 2026
Use of the IlluminOss Photodynamic Bone Stabilisation System Following Stereotactic Body Radiation Therapy for Limb-Sparing in Six Dogs With Presumptive Appendicular OsteosarcomaEmily A Pope, Vincent A Wavreille, Janis L Lapsley, et al.
Pageof 9